• Is There A Room For Non-Economic Criteria In The Decision Making Process In The Health Care Sector In Poland?

    May 1, 2014, 00:00

  • Integrating the child’s voice in adverse event reporting in oncology trials- Initial steps in the pediatric pro-ctcae initiative

    May 1, 2014, 00:00

  • The Association Between Sleep Problems, Sleep Medications And Falls In Community-Dwelling Older Adults- Results From The Health And Retirement Study 2010

    May 1, 2014, 00:00

  • Treatment Patterns and Cost of Care for Patients with Gastrointestinal Stromal Tumor (GIST) Treated with Imatinib

    May 1, 2014, 00:00

  • Patient preferences for frequency of glucagon-like peptide-1 receptor agonist (GLP-1RA) injections in the treatment of type 2 diabetes

    May 1, 2014, 00:00

  • Evaluation Of Adherence To Treatment Guidelines And Re-Hospitalization In Patients With Chronic Heart Failure- Thailand

    May 1, 2014, 00:00

  • Cost Implication Of Irrational Drug Prescription Under The National Health Insurance Scheme In Rural Ghana

    May 1, 2014, 00:00

  • Review of the usual treatment of adults with type 2 diabetes in Japan

    May 1, 2014, 00:00

  • Treatment Efficacy Of Once-Daily Fluticasone Furoate/Vilanterol (Ff/Vi) 92/22mcg Is Comparable With Twice-Daily Combination Therapies In Chronic Obstructive Pulmonary Disease (Copd)- A Mixed Treatment Comparison

    May 1, 2014, 00:00

  • Understanding Stakeholder Perspectives On Medicare’s Coverage With Evidence Development (Ced) Policy

    May 1, 2014, 00:00

  • The Importance Of Hta To Subsidize The Judicialization Of Health

    May 1, 2014, 00:00

  • Cost Effectiveness Analysis of Adding Radiation Therapy to Androgen Deprivation Therapies in Men with Locally Advanced Prostate Cancer in the United States

    May 1, 2014, 00:00

  • Pharmacist Vaccination Programs For Common Infectious Diseases- A Systematic Review Of The Literature On This Emerging Model Of Care

    May 1, 2014, 00:00

  • Pmsi Database ConsultationEvaluation Of Hospital Stay Length For Infantile Haemangioma In France Previous To And Subsequent To Propranolol Use

    May 1, 2014, 00:00

  • Cost-Effectiveness Of Various Clostridium Difficile Infection (CDI) Treatments In Patients With Recurrent Infections

    May 1, 2014, 00:00

  • Procedure (Implantation) Cost And Total Hospitalization Cost Of Patients Subjected To Cardiac Rhythm Management Devices Implantation- Results From A Single Tertiary Centre

    May 1, 2014, 00:00

  • Cost-Effectiveness Analysis Of Glycopirronium Versus Tiotropium And Fixed-Dose Combinations (Formoterol/Budesonide And Salmeterol/Fluticasone) For Copd In The Colombian Health Care System

    May 1, 2014, 00:00

  • Policymaker, Please Consider Your Needs Carefully- Does Outcomes Research in Relapsed or Refractory Multiple Myeloma Reduce Policymaker Uncertainty Regarding Value for Money of Bortezomib?

    Mar 1, 2014, 00:00

  • Cost-Effectiveness of Statins for Primary Prevention in Patients Newly Diagnosed with Type 2 Diabetes in The Netherlands

    Mar 1, 2014, 00:00

  • Socioeconomic Status and Nonadherence to Antihypertensive Drugs- A Systematic Review and Meta-Analysis

    Mar 1, 2014, 00:00

  • Mapping the FACT-P to the Preference-Based EQ-5D Questionnaire in Metastatic Castration-Resistant Prostate Cancer

    Mar 1, 2014, 00:00

  • Table of Contents

    Mar 1, 2014, 00:00

  • Long-Term Medical Costs and Life Expectancy of Acute Myeloid Leukemia- A Probabilistic Decision Model

    Mar 1, 2014, 00:00

  • Simultaneous Multioutcome Synthesis and Mapping of Treatment Effects to a Common Scale

    Mar 1, 2014, 00:00

  • Questionnaire to Assess Relevance and Credibility of Modeling Studies for Informing Health Care Decision Making- An ISPOR-AMCP-NPC Good Practice Task Force Report

    Mar 1, 2014, 00:00

  • Tools for Health Care Decision Making- Observational Studies, Modeling Studies, and Network Meta-Analyses

    Mar 1, 2014, 00:00

  • Should Linking Replace Regression When Mapping from Profile-Based Measures to Preference-Based Measures?

    Mar 1, 2014, 00:00

  • Quality-of-Life–Adjusted Hazard of Death- A Formulation of the Quality-Adjusted Life-Years Model of Use in Benefit-Risk Assessment

    Mar 1, 2014, 00:00

  • Using Time Trade-Off Methods to Assess Preferences Over Health Care Delivery Options- A Feasibility Study

    Mar 1, 2014, 00:00

  • Indirect Treatment Comparison/Network Meta-Analysis Study Questionnaire to Assess Relevance and Credibility to Inform Health Care Decision Making- An ISPOR-AMCP-NPC Good Practice Task Force Report

    Mar 1, 2014, 00:00

  • Core Discrete Event Simulation Model for the Evaluation of Health Care Technologies in Major Depressive Disorder

    Mar 1, 2014, 00:00

  • A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making- An ISPOR-AMCP-NPC Good Practice Task Force Report

    Mar 1, 2014, 00:00

  • The Timing and Probability of Treatment Switch under Cost Uncertainty- An Application to Patients with Gastrointestinal Stromal Tumor

    Mar 1, 2014, 00:00

  • Projecting Long-Term Graft and Patient Survival after Transplantation

    Mar 1, 2014, 00:00

  • Erratum

    Mar 1, 2014, 00:00

  • Instructions for Authors

    Mar 1, 2014, 00:00

  • Specification of the Utility Function in Discrete Choice Experiments

    Mar 1, 2014, 00:00

  • Antiparkinson Drug Adherence and Its Association with Health Care Utilization and Economic Outcomes in a Medicare Part D Population

    Mar 1, 2014, 00:00

  • Where Does the Money Go? Analyzing the Patient Experience in Safety-Net Hospitals

    Mar 1, 2014, 00:00

  • Copyright/Subscription

    Mar 1, 2014, 00:00

  • A Multistate Model and an Algorithm for Measuring Long-Term Adherence to Medication- A Case of Diabetes Mellitus Type 2

    Mar 1, 2014, 00:00

  • Table of Contents

    Jan 1, 2014, 00:00

  • Use of Bayesian Multivariate Meta-Analysis to Estimate the HAQ for Mapping Onto the EQ-5D Questionnaire in Rheumatoid Arthritis

    Jan 1, 2014, 00:00

  • Improving the Usefulness of Budget Impact Analyses- A U.S. Payer Perspective

    Jan 1, 2014, 00:00

  • EQ-5D Versus SF-12 in Coronary Patients- Are They Interchangeable?

    Jan 1, 2014, 00:00

  • Evaluating Direct Medical Expenditures Estimation Methods of Adults Using the Medical Expenditure Panel Survey- An Example Focusing on Head and Neck Cancer

    Jan 1, 2014, 00:00

  • Reviewer Acknowledgment

    Jan 1, 2014, 00:00

  • Differences in Health Services Utilization and Costs between Antihypertensive Medication Users Versus Nonusers in Adults with Diabetes and Concomitant Hypertension from Medical Expenditure Panel Survey Pooled Years 2006 to 2009

    Jan 1, 2014, 00:00

  • Development of a Symptom Index for Patients with Primary Brain Tumors

    Jan 1, 2014, 00:00

  • The Cost-Effectiveness of a Pharmacogenetic Test- A Trial-Based Evaluation of TPMT Genotyping for Azathioprine

    Jan 1, 2014, 00:00

  • Impact of Osteoporosis on High-Cost Chronic Diseases

    Jan 1, 2014, 00:00

  • Valuing the Health States Associated with Chlamydia trachomatis Infections and Their Sequelae- A Systematic Review of Economic Evaluations and Primary Studies

    Jan 1, 2014, 00:00

  • Health Utility Scores in Alzheimer’s Disease- Differences Based on Calculation With American and Canadian Preference Weights

    Jan 1, 2014, 00:00

  • Review- Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

    Jan 1, 2014, 00:00

  • Mental Health

    Dec 1, 2013, 00:00

  • The Cost-Effectiveness of Duloxetine in Chronic Low Back Pain- A US Private Payer Perspective—Author Response to Letter to the Editor

    Dec 1, 2013, 00:00

  • A Pilot Study of Multicriteria Decision Analysis for Valuing Orphan Medicines

    Dec 1, 2013, 00:00

  • Table of Contents

    Dec 1, 2013, 00:00

  • A Clinical Research Practice Datalink Analysis of Antidepressant Treatment Patterns and Health Care Costs in Generalized Anxiety Disorder

    Dec 1, 2013, 00:00

  • Mifamurtide for High-Grade, Resectable, Nonmetastatic Osteosarcoma Following Surgical Resection- A Cost-Effectiveness Analysis

    Dec 1, 2013, 00:00

  • Assessment of PRO Label Claims Granted by the FDA as Compared to the EMA (2006–2010)

    Dec 1, 2013, 00:00

  • Understanding the Economic Burden of Nonsevere Nocturnal Hypoglycemic Events- Impact on Work Productivity, Disease Management, and Resource Utilization

    Dec 1, 2013, 00:00

  • Editorial Board

    Dec 1, 2013, 00:00

  • Validation of Models That Estimate the Cost-Effectiveness of Improving Patient Adherence

    Dec 1, 2013, 00:00

  • Instructions for Authors

    Dec 1, 2013, 00:00

  • An Integrated Approach to Evaluating Alternative Risk Prediction Strategies- A Case Study Comparing Alternative Approaches for Preventing Invasive Fungal Disease

    Dec 1, 2013, 00:00

  • Development of a Disease-Specific Version of the EQ-5D-5L for Use in Patients Suffering from Psoriasis- Lessons Learned from a Feasibility Study in the UK

    Dec 1, 2013, 00:00

  • Improving model validation in HTA- Comments on the Guidelines of the ISPOR-SMDM Modeling Good Research Practices

    Dec 1, 2013, 00:00

  • Copyright/Subscription

    Dec 1, 2013, 00:00

  • The Cost-Effectiveness of Duloxetine in Chronic Low Back Pain- A US Private Payer Perspective

    Dec 1, 2013, 00:00

  • Utilization of Anti Spasticity Drugs in Multiple Sclerosis- Analysis from an Italian Administrative Database

    Nov 1, 2013, 00:00

  • Economics of Dialysis Dependence Following Acute Kidney Injury (AKI) in the Intensive Care Unit (ICU)

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Colombia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Linaclotide Compared to Antidepressants in the Treatment of Irritable Bowel Syndrome with Constipation in Scotland

    Nov 1, 2013, 00:00

  • Evaluation of Telemedicine Program (Ithaca)- Innovation in the Treatment of Arterial Hypertension Increasing the Compliance and Adherence in the Second Year of Its Implementation (2011-2012)

    Nov 1, 2013, 00:00

  • Bisphosphonates-Associated Osteonecrosis of Jaw in Cancer Patients- A Meta-Analysis

    Nov 1, 2013, 00:00

  • An Analysis of EQ-5D Quality of Life Data for a Cost-Effectiveness Analysis of Ivabradine Plus Standard Care Versus Standard Care Alone in Chronic HF

    Nov 1, 2013, 00:00

  • Patient Functioning in Generalized Anxiety Disorder Subjects with Partial Response to Prior SSRI Treatment- The Effect of Adjunctive Therapy with Pregabalin in Daily Medical Practice

    Nov 1, 2013, 00:00

  • A Systematic Literature Review on the Epidemiology and Economic Burden of Anaemia Associated with Chronic Kidney Disease

    Nov 1, 2013, 00:00

  • Systematic Literature Review of Economic Burden of Chronic Plaque Psoriasis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Chile

    Nov 1, 2013, 00:00

  • Self- Assesment of Health Professionals’ Communication Skills with Patients

    Nov 1, 2013, 00:00

  • Mapping and Analysing Pharmaceutical Policy Settings Worldwide

    Nov 1, 2013, 00:00

  • Application of New French Guidelines for Economic Evaluations- A Cost-Effectiveness Analysis of Apixaban in Patients with Non-Valvular Atrial Fibrillation in France

    Nov 1, 2013, 00:00

  • A Comparison of Methodologies for Estimating Survival in Patients Treated with Second-generation Tyrosine-kinase Inhibitors (TKIs) for Chronic Myeloid Leukaemia (CML)

    Nov 1, 2013, 00:00

  • Prescription Patterns of Antihypertensive Agents in T2DM Patients Visiting Tertiary Care Centre in North India

    Nov 1, 2013, 00:00

  • Supplementary Health Insurance in Turkey

    Nov 1, 2013, 00:00

  • Survival Analysis with Covariates in Combination with Multinomial Analysis to Parametrize Time to Event for Multi-State Models

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Education for Health Care Students in Bosnia and Herzegovina

    Nov 1, 2013, 00:00

  • Meta-Analysis of Efficacy of Romiplostim for Treatment of Immune Idiopathic Thrombocytopenia

    Nov 1, 2013, 00:00

  • Assessing the Relationship Between the Diabetes Health Profile and Diabetes Specific Clinical Indicators- Case for Tailored Therapeutics

    Nov 1, 2013, 00:00

  • Can Variation in Hospital Procedure Rates Identify Candidates for Health Technology Reassessment and Disinvestment?

    Nov 1, 2013, 00:00

  • Patterns of Disease Remission Among Patients with Rheumatoid Arthritis Receiving Their First Biologic in European Union

    Nov 1, 2013, 00:00

  • Impact of Bariatric Surgery on Obese Patients Management and Related Costs- A French National Claims Database Analysis Over the Period 2005 -2011

    Nov 1, 2013, 00:00

  • The Growing Role of Qualitative Interviews in Health Outcomes Research

    Nov 1, 2013, 00:00

  • Influence of Patient-Reported Outcomes on HTA Reimbursement Decisions

    Nov 1, 2013, 00:00

  • Total and Low-Density Lipoprotein Cholesterol Levels in High Risk Patients Treated with Atorvastatin Monotherapy in the United Kingdom

    Nov 1, 2013, 00:00

  • Investigating Safety-Appraoch in Saudi Arabia Ministry of Health Hospitals

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Fixed-Dose Combination (FDC) of Vildagliptin/Metformin for the Treatment of Diabetes Mellitus Type 2 in Mexico

    Nov 1, 2013, 00:00

  • Validity of Self-Reported Dose of Patients Using Wafarin in Clinical Practice

    Nov 1, 2013, 00:00

  • Custos Das Fraturas Osteoporóticas No Sistema Público De Saúde Brasileiro

    Nov 1, 2013, 00:00

  • Adherence to Treatment and Persistency in Patients Treated with VKA in France, Italy, Germany, Spain and the United Kingdom

    Nov 1, 2013, 00:00

  • Evaluación De Costo-Efectividad De La Trabeculoplastia Láser Selectiva Como Primera Opción De Tratamiento En Glaucoma Primario De Ángulo Abierto En Colombia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Childhood Rotavirus Vaccination in Germany

    Nov 1, 2013, 00:00

  • Level of Asthma Control and Health Care Utilization in Latin America

    Nov 1, 2013, 00:00

  • Therapy Sequences in Multiple Myeloma – A Clinical Model Study in Regards of a German Cost Context

    Nov 1, 2013, 00:00

  • Fatores Associados À Compra De Medicamentos Em Brasília- Uma Análise Econométrica Com Dados Transversais De Base Populacional

    Nov 1, 2013, 00:00

  • The Burden of Disease Attributable to Physical Inactivity in the Austrian Region of Burgenland

    Nov 1, 2013, 00:00

  • The Humanistic and Economic Burden of Venous Thromboembolism in Cancer Patients- A Systematic Review

    Nov 1, 2013, 00:00

  • Differential Resource Use and Costs Among Inpatients and Outpatients with Schizophrenia in Tianjin, China

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Ceftaroline Versus Linezolid or Vancomycin on the Top of Standard Therapy in the Treatment of Complicated Skin and Soft Tissues Infections in Russian Federation

    Nov 1, 2013, 00:00

  • Chronic Patients Response to the Implementation of International Non-Proprietary Name (INN) Prescribing in Greece

    Nov 1, 2013, 00:00

  • Relative Efficacy and Acceptability of Vortioxetine Versus Marketed Antidepressants

    Nov 1, 2013, 00:00

  • Explaining the Increased Health Care Expenditures Among Individuals with Co-Occurring Chronic Obstructive Pulmonary Disease and Gastroesophageal Reflux Disease- A Cost-Decomposition Analysis

    Nov 1, 2013, 00:00

  • The Influence of Improved Adherence and Persistence in Chronic Obstructive Pulmonary Disease (COPD) Costs- Systematic Review of the Literature

    Nov 1, 2013, 00:00

  • Three-Year Health Care Expenditures in Diabetic Patients Receiving Rapid-Acting Insulin Analogues Versus Those on Human Regular Insulin

    Nov 1, 2013, 00:00

  • Epidemiology, Treatment Outcomes and Costs of Treating Hepatitis C in Routine Care – Results from a Large Multicenter Trial

    Nov 1, 2013, 00:00

  • A Time-Motion Comparison of Itemized Treatment Costs in First Versus Subsequent Cycles of in Vitro Fertilization (IVF)- Treatments Can Optimized for Improving Outcomes While Increasing Patient Volumes in Cost-Constrained Regions

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in Mexico

    Nov 1, 2013, 00:00

  • Impact of Patient Weight Trajectory on Cost-Effectiveness of Treatments of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2013, 00:00

  • Dynamics of Quality of Life in Children with Cystic Fibrosis Aged 5-16 Years

    Nov 1, 2013, 00:00

  • Análisis De Costos Mediante Un Modelo Lineal Generalizado De Pacientes Mexicanos Con Sindrome De West

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Analysis of Cisplatin Plus Pemetrexed Doublet Induction Treatment Followed by Pemetrexed Maintenance Compared with Bevacizumab Plus Cisplatin Plus Gemcitabine Triplet Induction Treatment Followed by Bevacizumab Maintena ...

    Nov 1, 2013, 00:00

  • A Systematic Review of Antidepressants in Irritable Bowel Syndrome- A Qualitative Analysis

    Nov 1, 2013, 00:00

  • Economic Evaluation of Tips Compared to Large Volume Paracentesis in Patients with Refractory Ascites

    Nov 1, 2013, 00:00

  • A Budgetary Impact Analysis Model for Everolimus in the Treatment of ER+ HER2- Metastatic Breast Cancer in England and Wales

    Nov 1, 2013, 00:00

  • Attitudes, Beliefs and Behaviours of General Practitioners Regarding Vaccination- Development of a Characterisation Tool – Qualitative Steps

    Nov 1, 2013, 00:00

  • Assessment of the Perception and Practices with Respect to Antibiotic Usage in Public Through Social Media

    Nov 1, 2013, 00:00

  • Following the Western HTA Model in Latin America- A Self-Fulfilling Prophecy?

    Nov 1, 2013, 00:00

  • Treatment Costs of Ischemic Stroke Prevention and Management in Patients with Atrial Fibrillation (AF) in Latin America- Argentina, Brazil, Chile, and Venezuela

    Nov 1, 2013, 00:00

  • Utilization of the Hungarian Publicly Financed Health Care System by Third (Non EU) Country Citizens

    Nov 1, 2013, 00:00

  • Análise Comparativa Dos Anticoncepcionais Orais Com Diferentes Concentraçoes De Etinilestradiol Em Relação Aos Perfis De Eficácia E De Adesão

    Nov 1, 2013, 00:00

  • Systematic Literature Review in Moderate to Severe Ulcerative Colitis

    Nov 1, 2013, 00:00

  • The Impact of Indication Extensions on Pharmaceutical Prices

    Nov 1, 2013, 00:00

  • Health Outcomes of Female Anabolic-Androgenic Steroid Users

    Nov 1, 2013, 00:00

  • Cost-Utility of Active Surveillance for the Treatment of Localized Prostate Cancer in the Context of the German Health Care System

    Nov 1, 2013, 00:00

  • A Retrospective Study Comparing Compliance, Persistence, and Blood Pressure Control Between Free-Drug and Single-Pill Combination Therapies in Korean Hypertensive Patients

    Nov 1, 2013, 00:00

  • A Critical Appraisal of Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening- Making Appropriate Comparisons and Usefully Interpreting Results

    Nov 1, 2013, 00:00

  • Prescribing Patterns of Parkinson’s Disease

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Atorvastatin Compared to Simvastatin in the Prevention of Cardiovascular Diseases in the Czech Republic

    Nov 1, 2013, 00:00

  • The Economic Footprint of the Greek Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • Relationship Between Body Mass Index and Health Care Costs by Place of Service in Employed Adults

    Nov 1, 2013, 00:00

  • Using a Cause-Of-Death-Based Mortality Model to Identify the Individuals Who Would Benefit Most from Primary Prevention with Statins

    Nov 1, 2013, 00:00

  • Clinical Effectiveness Analysis of Deferasirox for the Treatment of Iron Overload Due to Frequent Blood Transfusions

    Nov 1, 2013, 00:00

  • Squaring the Circle- Innovative Contracting to Achieve Market Access for Innovative Products

    Nov 1, 2013, 00:00

  • Burden of Multiple Sclerosis and Unmet Needs in Brazil- Health Care Resource Utilization

    Nov 1, 2013, 00:00

  • Cost of Illness of Neuropathic Pain in Spain in 2012 from a Societal Perspective

    Nov 1, 2013, 00:00

  • Comparative Study of the Cost-Effectiveness of Trastuzumab in the Treatment of Breast Cancer in Different Countries

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Caspofungin Versus Voriconazole for Empiric Therapy in Turkey

    Nov 1, 2013, 00:00

  • Varicella Vaccine as Post-Exposure Prophylaxis – a Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Venous Thromboembolism in Gynae-Oncology Patients Post Surgery – Is Tinzaparin Prophylaxis an Effective Anticoagulant?

    Nov 1, 2013, 00:00

  • A Cost-Effectiveness Analysis of Ingenol Mebutate Gel for the Treatment of Actinic Keratosis- A Scottish Perspective

    Nov 1, 2013, 00:00

  • Measuring Treatment Effects on Rare Events Using Meta-Analysis- An Assessment of Existing Methods

    Nov 1, 2013, 00:00

  • A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer

    Nov 1, 2013, 00:00

  • Indirect and Direct Savings Resulted from Parallel Trade of Pharmaceuticals in Poland – Results of Valuation Sales Data from Public Pharmacies

    Nov 1, 2013, 00:00

  • Appropriate Evidence Sources for Populating Decision Analytic Models Within Health Technology Assessment (HTA)- A Systematic Review of HTA Manuals and Health Economic Guidelines

    Nov 1, 2013, 00:00

  • Evaluation of the Policies Implemented to Monitor Prescription and Reduce Pharmaceutical Expenditure at the University General Hospital of Patras, Greece

    Nov 1, 2013, 00:00

  • Pivotal Studies of Orphan Medicinal Products – an Analysis of Quality of Clinical Evidence

    Nov 1, 2013, 00:00

  • Screening Strategies for Heart Failure in Patients with Type 2 Diabetes- Assessing Cost-Effectiveness in Those Aged 60 Years or Over

    Nov 1, 2013, 00:00

  • Demineralised Bone Matrix (DBM) Versus Iliac Crest Bone Graft (ICBG) for Lumbar Spinal Fusion Procedures in the United Kingdom; A Budget-Impact Analysis

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Benefits of Citicoline in the Treatment of Acute Ischemic Stroke in Russia

    Nov 1, 2013, 00:00

  • Pertussis in Brazilian Children- Mortality, Length of Stay, and Costs in Hospitalized Patients

    Nov 1, 2013, 00:00

  • Epidemiological and Economic Impact of Chronic Kidney Disease in Patients with Hypertension and Diabetes in Colombia

    Nov 1, 2013, 00:00

  • Meta-Analysis of Quality of Life in Coronary Heart Disease

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Etanercept in the Treatment of Rheumatoid Arthritis in Institutional Market in Ecuador

    Nov 1, 2013, 00:00

  • Chronic Patients’ Access to Physicians Services in Times of Economic Crisis

    Nov 1, 2013, 00:00

  • The Relative Economic Value of Ipilumumab in Colombia

    Nov 1, 2013, 00:00

  • The Impact of Smoking on Hospital Costs in Times of Crisis; An Additional Burden to the Vulnerable Greek Health Care System

    Nov 1, 2013, 00:00

  • Quality Improvement Initiatives for Patients on Warfarin in Primary Care

    Nov 1, 2013, 00:00

  • The Costs of Surgical Aortic Valve Replacement in France

    Nov 1, 2013, 00:00

  • Individually Tailored Elastic Compression Therapy for the Prevention of Post Thrombotic Syndrome

    Nov 1, 2013, 00:00

  • Quality Criteria for the Development of Implant Registries

    Nov 1, 2013, 00:00

  • Network Meta-Analysis with Fractional Polynomials for Repeated Trough FEV1 Measures in COPD- Aclidinium Bromide 400 μG Bid Versus Tiotropium 18 μG QD

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Early Versus Delayed Hepatitis C Virus (HCV) Treatment with Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy in Adults Aged 40+ in France

    Nov 1, 2013, 00:00

  • A Cost-Utility Analysis of Everolimus Plus Exemestane for the Treatment of ER+ HER2- Metastatic Breast Cancer in the United Kingdom

    Nov 1, 2013, 00:00

  • Cost Analysis of Pulmonary Arterial Hypertension in a Tertiary Care Setting in Mexico City

    Nov 1, 2013, 00:00

  • ePRO Migration and Usability Testing of Patient-Reported Outcome (PRO) Measures

    Nov 1, 2013, 00:00

  • Incidence/Prevalence, Risk Factors and Complications of Type 2 Diabetes Mellitus in Indian Patients- A Systematic Review and Meta-Analysis

    Nov 1, 2013, 00:00

  • The Use of European Electronic Health Records to Investigate Cancer Treatment Pathways

    Nov 1, 2013, 00:00

  • The Hybrid Purchaser-Provider Split in England- Should Europe Follow Suit?

    Nov 1, 2013, 00:00

  • How Does Prescription of Generic Drugs Spread Out?- Data Mining and Visualization by Using Prescription Data Form Acute Care Hospitals Nationwide

    Nov 1, 2013, 00:00

  • Treatment Patterns Among Type 2 Diabetes Mellitus Patients in Dubai

    Nov 1, 2013, 00:00

  • Agranulocytosis Detection Outcome By Clozapine Treatment (Adoc Study) in Psychiatry- A Cost-Effectiveness Study

    Nov 1, 2013, 00:00

  • Resource Utilization and Costs for Patients with Inflammatory Bowel Diseases in Italy- A Population-Based Assessment

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of School-Based Health Promotion in Canada- A Life-Course Modeling Approach

    Nov 1, 2013, 00:00

  • Hepatocellular Carcinoma- An Epidemiological and Management Survey-Based Analysis in Italy

    Nov 1, 2013, 00:00

  • Do Policy Measures Impact on Cost Consciousness of Health Care Professionals?

    Nov 1, 2013, 00:00

  • Análisis Costo-Efectividad De Intervenciones Para El Manejo Del Trastorno Depresivo Mayor (TDM) En Pacientes Con Virus De La Inmunodeficiencia Humana (VIH+) Que Inician Tratamiento Antirretroviral De Gran Actividad (TARGA)

    Nov 1, 2013, 00:00

  • Impacto Financiero Del Tratamiento Farmacológico En Pacientes Adultos Con Enfermedad De Gaucher Tipo 1 En México

    Nov 1, 2013, 00:00

  • Paediatric Tuberculosis - Costs to the Irish Health Care Payer

    Nov 1, 2013, 00:00

  • Health Related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease in North India

    Nov 1, 2013, 00:00

  • Cost of Treatment After Renal Transplantation in Iran- Should Government Continue Paying for New Expensive Immunosuppressive Drugs?

    Nov 1, 2013, 00:00

  • Design of Lupus Impact Tracker (LIT) Validation Study in Five European Clinical Practice Settings

    Nov 1, 2013, 00:00

  • Comparison Between Everolimus (Afinitor®) and Chemotherapy Agents (Capecitabine, Docetaxel and Doxorubicin) for the Treatment of Hormone Receptor Positive (HR+) HER2 Negative (HER2–) Advanced or Metastatic Breast Cancer

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness and Cost-Utility Analysis of Belimumab for the Treatment of Patients with Systemic Lupus Erythematosus in Portugal

    Nov 1, 2013, 00:00

  • Treating Psoriatic Arthritis with Biological Disease Modifying Antirheumatic Drugs- Systematic Review and Meta-Analysis to Evaluate Efficacy and Safety

    Nov 1, 2013, 00:00

  • Accessibility of Orphan Drugs in France, United Kingdom and Germany- Different Approaches with Regard to HTA and Prices

    Nov 1, 2013, 00:00

  • Number of Submissions Needed to Reach a Positive Reimbursement Decision from SMC, CADTH, and PBAC

    Nov 1, 2013, 00:00

  • Direct-To-Patient Contact and Proactive Pharmacovigilance System- A Case Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analyses of Natalizumab for 2nd Line Versus Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients in Brazil

    Nov 1, 2013, 00:00

  • Clinical and Health Economic Evidence Requirements for Obtaining Health Insurance Coverage for Innovative Medical Devices in Germany

    Nov 1, 2013, 00:00

  • Can We Use the EQ-5D Only for Assessing the Quality of Life of Patients with Osteoporosis?

    Nov 1, 2013, 00:00

  • Carbon Cost-Effectiveness of Cocooning Immunization Against Pertussis in England and Wales- An Ecological Perspective

    Nov 1, 2013, 00:00

  • Differences in Medical Cost and Survival Between Trial and Non-Trial Patients with Acute Myeloid Leukaemia – A UK Population-Based Propensity Analysis

    Nov 1, 2013, 00:00

  • The Measurement of Health-related Quality of Life- German Findings from the Multi-Instrument Comparison (MIC) Study

    Nov 1, 2013, 00:00

  • Disease Burden Among Patients with Psoriatic Arthritis Who Have Experienced First Line Tumor Necrosis Factor Inhibitor Regimen Failure in the European Union

    Nov 1, 2013, 00:00

  • Costo Del Automonitoreo Glucémico En Pacientes En Tratamiento Combinado Oral Y Con Insulina En Argentina

    Nov 1, 2013, 00:00

  • Confirmatory Factor Analysis and Evaluation of Clinically Important Differences in Menopause-Specific Quality of Life Associated with Bazedoxifene/Conjugated Estrogens in a Vulvar/Vaginal Atrophy Population

    Nov 1, 2013, 00:00

  • The Health and Economic Impact of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) in Columbia- A Transmission Dynamic Model-Based Evaluation

    Nov 1, 2013, 00:00

  • Costs and Effectiveness of Non-Smoking Clinic

    Nov 1, 2013, 00:00

  • 4-Valent Vaccine Patients – Statistical Assessment of a New Estimation Methodology

    Nov 1, 2013, 00:00

  • Iceberg Phenomenon of Heart Failure in Hospitalized Patients- A Multicentric Cross Sectional Study

    Nov 1, 2013, 00:00

  • Construcción De Un Modelo De Priorización Aplicable a Latinoamérica – El Caso De Colombia

    Nov 1, 2013, 00:00

  • Methodology of an Observational Study to Evaluate the Care Map of Women with Postmenopausal Osteoporosis (PMO) in Switzerland

    Nov 1, 2013, 00:00

  • Long-Term Fiscal Implications of Funding Assisted Reproductive Therapies- A Generational Accounting Model for Spain

    Nov 1, 2013, 00:00

  • Cost Minimization Analysis of the Dienogest Use in Patients with Endometris under Brazilian Public and Private Perspective

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Intravenous Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Multiforme in Russia

    Nov 1, 2013, 00:00

  • Item Refinement and Psychometric Testing of a Novel Survey for Evaluating Patient Perception and Preference for Haemophilia a Treatment

    Nov 1, 2013, 00:00

  • Assessment of Generic Drug Policy Implementation by Measuring Persistence with Antihypertensive Drug Therapies After Patent Expiry

    Nov 1, 2013, 00:00

  • Systematic Review on the Impacts of Strict Pharmaceutical Price Controls

    Nov 1, 2013, 00:00

  • The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany

    Nov 1, 2013, 00:00

  • Custo-Efetividade Do Tratamento Para Osteoporose Na Pos-Menopausa No Brasil

    Nov 1, 2013, 00:00

  • The Use of Data from Published Kaplan-Meier Survival Curves in NICE HTAs

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Metastatic Colorectal Cancer (mCRC)- A Utilities Study in the United Kingdom and the Netherlands

    Nov 1, 2013, 00:00

  • Retrospective Analysis of Oncology Indications Utilizing Drug Expenditures from 2005 to 2012 in the Republic of Srpska

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Induction Treatment with Bortezomib Added to Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation in Germany

    Nov 1, 2013, 00:00

  • The Effectiveness of Statins in the Treatment of Cardiovascular Disease- Cross-Sectional Study with Paired Groups from Electronic Patient Records

    Nov 1, 2013, 00:00

  • Patient Reported Outcomes with Multiple Sclerosis in Slovakia

    Nov 1, 2013, 00:00

  • Factorial Invariance of the Whoqol-Old Across Gender, Age, and Resident Area in Taiwan

    Nov 1, 2013, 00:00

  • Likelihood of Use and Perception Towards Biosimilars in Rheumatoid Arthritis Arena- Survey of Rheumatologists in European Union, Brazil, Japan and China

    Nov 1, 2013, 00:00

  • A Systematic Review of Patient Reported Outcomes in Glaucoma

    Nov 1, 2013, 00:00

  • Effectiveness and Cost Analysis of the Smoking Cessation Program in the Public Health System in Brazil

    Nov 1, 2013, 00:00

  • Uptake of Denosumab in the Treatment of Osteoporosis in the Czech Republic

    Nov 1, 2013, 00:00

  • Health State (QALY) Values for Multiple Sclerosis- A Report Using Data from the United Kingdom South West Impact of Multiple Sclerosis (SWIMS) Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Alendronate Therapy for Secondary Prevention of Osteoporotic Fractures

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Cinacalcet Chronic Kidney Disease Patients on Dialysis with Secondary Hyperparathyroidism in Brazilian Public Health Care System (SUS)

    Nov 1, 2013, 00:00

  • Trends in Chemotherapy Setting and Costs from 2005 to 2012- A Case Study Using Bevacizumab

    Nov 1, 2013, 00:00

  • A Price Comparison Study of Recent Drugs in EU5, 2008-2012

    Nov 1, 2013, 00:00

  • Disease Burden in Epilepsy Associated with Tuberous Sclerosis Complex- Systematic Review

    Nov 1, 2013, 00:00

  • Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erithematosus in the Italian Setting- A Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • The Cost of Producing a Unit of Blood in Hospitals- A Nationwide Economic Analysis for the Case of Greece

    Nov 1, 2013, 00:00

  • A Cost Analysis of Medication for Patients with Type 2 Diabetes Mellitus (T2DM) – How This Varies According to Body Mass Index (BMI) Status, Age, Gender and Co-Morbidity

    Nov 1, 2013, 00:00

  • Use of Multivariate Bayesian Evidence Synthesis to Reduce Uncertainty Around Clinical Effectiveness and Quality of Life Estimates

    Nov 1, 2013, 00:00

  • Exploring Dependence on Others in Alzheimer’s Disease

    Nov 1, 2013, 00:00

  • The Impact of DSM-5 on the Development of Drugs to Treat Schizophrenia

    Nov 1, 2013, 00:00

  • Clinical Outcomes Assessments in Schizophrenia- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Short Run Dynamics of Inadequate Pain Relief (IPR)- Evidence from a European Multinational Survey of Real World Therapies (SORT)

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Assessment of Different Tactics of COPD Treatment in Russia

    Nov 1, 2013, 00:00

  • Economic Impact of a Smoking Cessation Program in Mexico- Enrolling Employees and Employers

    Nov 1, 2013, 00:00

  • Clinical and Economic Analysis of Mometasone Furoate Nasal Spray in the Treatment of Rhinosinusitis in Mexico

    Nov 1, 2013, 00:00

  • Costs and Outcomes Associated with Multidrug Resistant Staphylococcus Aureus Bacteremia

    Nov 1, 2013, 00:00

  • A Systematic Review of Economic Evidence in Hepatitis C- An Overview of Cost, Utility and Cost-Effectiveness Data

    Nov 1, 2013, 00:00

  • Incorporating Stakeholder Input into Budget Impact Models to Compare Stem Cell Mobilization Strategies

    Nov 1, 2013, 00:00

  • Recruting Physicians for Health Outcome and Post-Approval Studies- Benefits of a Managed Physician Panel

    Nov 1, 2013, 00:00

  • Cost-Comparison Between Different Treatment Regimens in Diabetes Mellitus in Germany Based on Long Acting Insulins

    Nov 1, 2013, 00:00

  • How to Select the Right Cost-Effectiveness Model? A Systematic Review and Stepwise Approach for Transferring an Existing Health Economic Model for Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • A Comparison of Coverage and Reimbursement Decisions in Germany (AMNOG) and Scotland (SMC)

    Nov 1, 2013, 00:00

  • Analysis of the Pricing and Market Access Landscape of Orphan Drugs in Latin America

    Nov 1, 2013, 00:00

  • Burden of Dose Escalation with Biologics in Rheumatoid Arthritis- A Review of Frequency and Costs

    Nov 1, 2013, 00:00

  • Modelling Uncertain Future Events in Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • An Assessment of the Use of Utility Data in Long-Term Cost-Effectiveness Models of Lipid Lowering Therapies

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Posaconazole Versus Fluconazole for Prevention of Invasive Fungal Infections in Patients with Graft-Versus-Host Disease in Sweden

    Nov 1, 2013, 00:00

  • Compliance Protects Against Fracture in Women with Postmenopausal Osteoporosis in Hungary

    Nov 1, 2013, 00:00

  • Direct Health Care Costs of Patients Switching Biologic Therapies in Chronic Plaque Psoriasis

    Nov 1, 2013, 00:00

  • Relationship Between Medication Adherence and Quality of Life in COPD – Systematic Review

    Nov 1, 2013, 00:00

  • Standardized Tool for Measurement of Health Services Costs and Utilization in a Sample with Mental Disorders- Translation, Cultural Adaptation and Interrater Reliability of the Client Sociodemografic and Service Receipt Inventory Brazilian ...

    Nov 1, 2013, 00:00

  • Economic Impact of Improving the Accuracy of Blood Glucose Self-Monitoring on the Spanish Health Service

    Nov 1, 2013, 00:00

  • A Cost-Analysis of Stereotactic Radiotherapy in Lung Cancer

    Nov 1, 2013, 00:00

  • Revised Scoring of the WPAI-Hep C Improves Assessment of Missed Work and Work Impairment in HCV Clinical Trials

    Nov 1, 2013, 00:00

  • The Disease Burden of Influenza in Germany

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Peginterferon Alfa and Ribavirin for the Treatment of Children and Young People with Chronic Hepatitis C from the Perspective of the NHS in England and Wales

    Nov 1, 2013, 00:00

  • Impacto En La Productividad Laboral De Una Cohorte De Pacientes Con Artritis Reumatoide Tratados Con Etanercept (Enbrel®) En Colombia

    Nov 1, 2013, 00:00

  • Pilot Testing of the Polish Pre-Final Version of “Disabilities of the Arm, Shoulder and Hand” (Dash) Questionnaire

    Nov 1, 2013, 00:00

  • Evaluating Different Modes of Radiotherapy Based on a Patient-Level Simulation Model

    Nov 1, 2013, 00:00

  • Inpatient Hospital Costs of Febrile Neutropenia (FN) as a Consequence of Chemotherapy (CHT) for Breast Cancer (BC) and Non-Hodgkin Lymphoma (NHL) in Switzerland

    Nov 1, 2013, 00:00

  • Development of the Schizophrenia Caregiver Questionnaire- Modification of the Zarit Burden Interview Informed by Qualitative Insights

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Gemcitabine Plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan

    Nov 1, 2013, 00:00

  • Counting the Cost of Meningococcal Disease in France

    Nov 1, 2013, 00:00

  • The Relationship Between Treatment Satisfaction and Adherence in COPD Patients in 5 Countries

    Nov 1, 2013, 00:00

  • Relevance of a National Forecast Growth Rate, as a Regulation Tool of the Expensive Hospital Drug Spending, in France

    Nov 1, 2013, 00:00

  • Quantifying Health Care Efficiency- A Review of Published Time and Motion Study Design Parameters Referenced in Pubmed Between 2008-2013

    Nov 1, 2013, 00:00

  • Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also known as C. Difficile-Associated Diarrhoea (CDAD) in Ireland

    Nov 1, 2013, 00:00

  • Relationship Between Modelling Approach and Reported Outcomes- Case Studies of Models for the Treatment of Schizophrenia

    Nov 1, 2013, 00:00

  • Resource Consumption Evaluation Associated with Rituximab Administration in Portugal

    Nov 1, 2013, 00:00

  • Household Feeding Practices for the Sick Under Five Children; Gucha South District-Kisii County, Kenya

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Type 2 Diabetes in Poland- Comparison with General Population Using EQ-5D Questionnaire

    Nov 1, 2013, 00:00

  • Effect of Ivabradine on Thai Chronic Stable Angina Pectoris Patients

    Nov 1, 2013, 00:00

  • Economic Analysis of Use of Harmonic Devices in Inpatient Laparoscopic Cholecystectomy in the United States

    Nov 1, 2013, 00:00

  • Current Situation of Oral Anticancer Treatments Use in Fran The Actor Study (Analysis of Cancer Treatments Given Orally)

    Nov 1, 2013, 00:00

  • Mapping from PDQ-39 and PDQ-8 Onto EQ-5D Utility Index in Patients with Parkinson’s Disease- Extended Analysis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of First-Line Treatment of Advanced Metastatic Non Small Cell Lung Cancer- A Systematic Review of Economic Models

    Nov 1, 2013, 00:00

  • Conceptual and Practical Considerations when Dealing with Missing Utility Data in Longitudinal Trials, and Subsequent Use in Cost-Effectiveness Analyses

    Nov 1, 2013, 00:00

  • Comparison of Treatment Satisfaction in Patients with Asthma Taking Leukotriene Modifiers Verus Those Taking Inhaled Corticosteroids

    Nov 1, 2013, 00:00

  • Application of Copulas in Economic Evaluation

    Nov 1, 2013, 00:00

  • Canadian Private Payers’ Perceptions and Expectations of Submission Requests for Drug Reimbursement Submitted by the Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • Effectiveness of Different Dosage Regimen of Pralidoxime in Organophosphorus Poisoning in Tertiary Care Hospital

    Nov 1, 2013, 00:00

  • Multi-Criteria Benefit-Risk Assessment of Biological Agents in the Treatment of Moderate to Severe Psoriais- A Stochastical Approach

    Nov 1, 2013, 00:00

  • Public Health Impact and Cost Effectiveness of Pneumococcal Vaccination for Adults in Puerto Rico

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Boceprevir Add-On Treatment of Hepatitis C Virus Genotype 1 Patients in Denmark

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Aspects of Actovegin and Solcoseryl in the Treatment of Russian Patients with Acute Cerebrovascular Accidents

    Nov 1, 2013, 00:00

  • Reliability and Validity of the Pediatric Quality of Life Inventory Generic Core Scales for Dutch Children with Functional Constipation

    Nov 1, 2013, 00:00

  • Obtaining Optimal Personalized Surveillance Strategies for Patients with Screen-Detected Colorectal Adenomas Using Discrete Event Simulation

    Nov 1, 2013, 00:00

  • Impact of Autism Spectrum Disorders on the Family – A National Perspective

    Nov 1, 2013, 00:00

  • Side-Effects of Antiepileptic Drugs- The Economic Burden

    Nov 1, 2013, 00:00

  • Real World Incidence of Type 2 Diabetes (T2D) Complications Leading to Hospitalization in Fran The Recode Study

    Nov 1, 2013, 00:00

  • Beta-Thalassemia Patients Survey on Deferrization Therapy

    Nov 1, 2013, 00:00

  • How Complex Is the Competition in Regulated Pharmaceutical Markets?

    Nov 1, 2013, 00:00

  • Is Hospitalized Multi-Morbidity in Adults Determining Costs of Re-Admission? Evidence from a Multicentric Cross Sectional Study in Argentina

    Nov 1, 2013, 00:00

  • A Mixed Treatment Comparison (MTC) to Compare Progression Free Survival (PFS) Associated with Different Chemotherapy Regimens for Platinum-Sensitive or Partially Platinum-Sensitive Recurrent Advanced Ovarian Cancer

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Systematic Testing for Lynch Syndrome in Patients Newly Diagnosed with Colorectal Cancer in the United Kingdom

    Nov 1, 2013, 00:00

  • G-Ba Assessments of Oncology Trials- Is Increased Overall Survival a “Must Have”?

    Nov 1, 2013, 00:00

  • Lower Short-Term Health Care Cost with the Accu-Chek Aviva Expert System in Multiple Daily Insulin Injection (MDI) Treated Diabetes Patients - Learnings from the Automated Bolus Advisor Control and Usability Study (ABACUS)

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Botulinum Toxin a Therapy for Upper Limb Spasticity in the United Kingdom

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Linezolid Versus Vancomycin in the Treatment of Ventilator Associated Pneumonia in Jamaica

    Nov 1, 2013, 00:00

  • What Factors Predict the Decision to Treat Acute Coronary Syndrome Invasively? Evidence from Clinical Practice

    Nov 1, 2013, 00:00

  • Evolution of Oral Anticancer Treatments Use in France from 2004 – 2012- Re-Actor Study (Retrospective Analysis of Cancer Treatments Given Orally)

    Nov 1, 2013, 00:00

  • Health State in Patients with Atrial Fibrillation on New Oral Anticoagulants as Assessed with the New EQ-5D-5L Questionnaire- Prefer in AF Registry

    Nov 1, 2013, 00:00

  • Telemonitoring After Discharge from Hospital with Heart Failure – Cost-Effectiveness Modelling of Alternative Service Designs

    Nov 1, 2013, 00:00

  • Evaluation of the Burden of Illness of Colorectal Cancer Among Veteran Patients in the United States

    Nov 1, 2013, 00:00

  • Systematic Review on the Cost-Effectiveness of Therapeutic Education to Prevent the Development and Progression of Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Comparing the Value of Different HTA Decision Making Process- Evaluating the Evaluators

    Nov 1, 2013, 00:00

  • Literature Review and Assessment to Populate a Decision-Analytic Model Evaluating a Novel Prognostic in Early Lung Cancer

    Nov 1, 2013, 00:00

  • Level and Factors Impacting the Patient Dissatisfaction in the Primary Care Visits Based on the Cross-Section Measurement – a Prospective Finnish Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Enzyme Replacement Therapy (ERT) with Alglucosidase Alfa in Classic-Infantile Patients with Pompe Disease

    Nov 1, 2013, 00:00

  • Do Nice Evidence Review Groups (ERG) Focus on Different Aspects of Manufacturer Submissions in Oncology?

    Nov 1, 2013, 00:00

  • EMA Approval of Drugs on the Basis of Pivotal Non-Comparative Phase II Trial Data

    Nov 1, 2013, 00:00

  • Patient-Level Costs of Cardiovascular Events and Procedures- How Robust Is the Evidence?

    Nov 1, 2013, 00:00

  • Influence of One Week Education Program on the Knowledge and Approach of Pharmacy Students Towards Diabetes Mellitus

    Nov 1, 2013, 00:00

  • Japanese Representation in Leading General Medicine and Basic Science Journals- A Comparison of Two Decades

    Nov 1, 2013, 00:00

  • Spectacle Independence and Vision-Related Quality of Life in Cataract Surgery Patients Following Implantation of a Multifocal Intraocular Lens

    Nov 1, 2013, 00:00

  • Cost-Consequence Analysis of a Treatment Strategy Including Ponatinib Compared to a Treatment Strategy Including Only the 2nd Generation Tyrosine Kinase Inhibitors (2g TKIs), Dasatinib or Nilotinib, in Resistant Patients with Philadelphia C ...

    Nov 1, 2013, 00:00

  • The Analysis of Costs and Reimbursements for Lung Cancer Treatment in the Czech Republic

    Nov 1, 2013, 00:00

  • Guidance for Partnership Working Between CatSalut and the Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • Table of Contents

    Nov 1, 2013, 00:00

  • Acute Exposure of Bisphenol-A from Electronic Gadgets Does Not Induce Oxidative Stress in the Rat Brain

    Nov 1, 2013, 00:00

  • Cost Assessment of Metastatic and Non-Metastatic Castration-Resistant Prostate Cancer Patient-Management in Spain

    Nov 1, 2013, 00:00

  • Description of Treatment Pathways in Chronic Diseases Using Large General Practitioner Longitudinal Data- The Example of Pharmaco-Therapy in Parkinson’s Disease in the United Kingdom

    Nov 1, 2013, 00:00

  • Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community

    Nov 1, 2013, 00:00

  • Sustained Improvements in Productivity at Paid Work and Within Household, and Increased Participation in Daily Activities Over Time with Certolizumab Pegol in Patients with Psoriatic Arthritis- 48-Week Results from the Rapid-PsA Study

    Nov 1, 2013, 00:00

  • The Cost-Utility of Insulin Degludec Compared with Current Standard of Care in the Management of Type One and Type Two Diabetes Mellitus in Belgium

    Nov 1, 2013, 00:00

  • Treatments for EGFR Mutation Positive NSCLC – A Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Economic Burden of Venous Thromboemoblism Across Patient Populations- A Literature Review

    Nov 1, 2013, 00:00

  • A Novel Algorithm Using Claims Data to Identify Patients with Castration-Resistant Prostate Cancer (CRPC)

    Nov 1, 2013, 00:00

  • Management of Obese Women During Pregnancy Across Europe According to Clinical Practice Guidelines

    Nov 1, 2013, 00:00

  • Measuring Patient-relevant Treatment Benefit in Dermatology – Development and Validation of the Short Questionnaire “Patient Benefit Index 2.0”

    Nov 1, 2013, 00:00

  • Evaluation of the Cost-Effectiveness of the Capsaicin Patch Qutenzatm for the Treatment of Peripheral Neuropathic Pain in the United Kingdom

    Nov 1, 2013, 00:00

  • Economic Impact of Pruritus Among End-Stage Renal Disease Patients Receiving Hemodialysis

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Evaluation of the Oral Hypoglycemic Agents in the Treatment of Type 2 Diabetes Mellitus Patients in the Russian Federation

    Nov 1, 2013, 00:00

  • The French Public Health Care System- An Original Way for Cost Saving

    Nov 1, 2013, 00:00

  • The Importance of Patient Reported Outcomes in Reimbursement of Orphan Products in Europe

    Nov 1, 2013, 00:00

  • Utility Values Used in National Institute for Health and Care Excellence (NICE) Technology Appraisals of Medicines for 4 Metastatic Cancers

    Nov 1, 2013, 00:00

  • Measurement of Societal Medical Care Preferences with the Same Cost Per Qaly- A Discrete Choice Study

    Nov 1, 2013, 00:00

  • Comparison of Markov and Discrete Event Simulation Modeling Techniques with Application to Cost Effectiveness Analyses

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Rivaroxaban in the Prevention of Stroke in Non-Valvular Atrial Fibrillation Patients in Italy

    Nov 1, 2013, 00:00

  • Patient Satisfaction with HIV Therapies- Focus on Adherence to Treatment

    Nov 1, 2013, 00:00

  • Economic Evidence of Surgical Procedures in Cancer- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • A Lesson Learnt from Avastin®- - Bevacizumab Induced Hypertension as a Predictive Biomarker of Patient Response in Overcoming Regulatory and Health Technology Assessment (HTA) Hurdles

    Nov 1, 2013, 00:00

  • Cost Associated with Adverse Events and Health Care Resources Utilization in Hepatitis C Virus Infection in Quebec, Canada

    Nov 1, 2013, 00:00

  • The Cost of Treating Squamous Cell Carcinoma of the Anus (SCCA) in England- Results from an Empirically Calibrated Model

    Nov 1, 2013, 00:00

  • Methodological Challenges of Cost-Of-Illness Studies on Dementia- An International Systematic Review

    Nov 1, 2013, 00:00

  • Cost and Length of Stay Associated with Vancomycin-Induced Nephrotoxicity

    Nov 1, 2013, 00:00

  • Application of a Data Visualization Tool- Treatment Patterns of Veteran Patients with Ankylosing Spondylitis

    Nov 1, 2013, 00:00

  • Clinical Outcomes in Schizophrenia Treated with Donepezil in Combination with Antipsychotics

    Nov 1, 2013, 00:00

  • Comparing Virtual Colonography with Conventional Colonoscopy for Colorectal Cancer Screening- What are the Drivers of Cost-effectiveness?

    Nov 1, 2013, 00:00

  • Cost Analysis of Anti-Migraine Prescribing Using a Claims Database

    Nov 1, 2013, 00:00

  • Patterns of Use of Tests to Diagnose and Assess Disease Progression in Multiple Sclerosis (MS)- A Multicountry Comparison

    Nov 1, 2013, 00:00

  • Coverage with Evidence Development in Sweden – Formality or Effective Way to Reduce Uncertainty?

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Linaclotide in the Treatment of Irritable Bowel Syndrome with Constipation in Belgium

    Nov 1, 2013, 00:00

  • Trends in Reimbursement Decisions in Ireland- An Analysis of the NCPE Database from an Industry Perspective

    Nov 1, 2013, 00:00

  • Comparative Costs Analysis of Conventional Strategy Versus Step-Down Strategy with Linezolid in the Treatment of Nosocomial Pneumonia Caused by Gram Positive Bacteria in Mexico

    Nov 1, 2013, 00:00

  • Multi-Dimensional Capture of Patient-Relevant Endpoints in Regulatory Trials and Health Technology Assessments in Oncology Two Years After Introduction of the German Amnog Health Care Reform

    Nov 1, 2013, 00:00

  • Atopic Dermatitis in Adults- Design and Validation of a Specific Burden Questionnaire

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Treatment of Spasticity with Botulinum Toxin Type A

    Nov 1, 2013, 00:00

  • Assessing the Impact of Organized Screening for Abdominal Aorta Aneurysms in Austria – Following Eunethta Core Information

    Nov 1, 2013, 00:00

  • The Cost Effectiveness of Peginterferon Alfa and Ribavirin for the Treatment of Hepatitis C in Children and Young People

    Nov 1, 2013, 00:00

  • Network Meta-Analysis of Approved Biologic Interventions for the Maintenance of Response in Ulcerative Colitis

    Nov 1, 2013, 00:00

  • Impact of Short Periods with Improved or Worsened INR Control on Life Expectancy and QALYs in Patients with Atrial Fibrillation

    Nov 1, 2013, 00:00

  • Quadrivalent Versus Trivalent Influenza Vaccine- Is It Good Value for Money?

    Nov 1, 2013, 00:00

  • A Review of Cost-Effectiveness Evaluations as Part of National HTA Assessments of Biologic Dmards in the Treatment of Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • The Burden of Treatment Change in Major Depressive Disorder- Comparison of Switch Versus Non-Switch Patients in the Perform Study

    Nov 1, 2013, 00:00

  • Adherence by Spanish Retinologists to the Guidance for the Management of Patients with Wet Age-Related Macular Degeneration

    Nov 1, 2013, 00:00

  • Economic Analysis of the Prevention of Medical Sharps Injuries with Safety-Engineered Devices- A Systematic Review

    Nov 1, 2013, 00:00

  • The Influence of Choice Task Layout on the Outcomes of a Discrete Choice Experiment

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Screening for Silent Atrial Fibrillation After Ischaemic Stroke

    Nov 1, 2013, 00:00

  • Impact of Reimbursement of Medicines on Economic Accessibility Level for Working Population in Republic of Moldova

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Patients Previously Treated with Docetaxel from the Perspective of the Brazilian Private Health Care System

    Nov 1, 2013, 00:00

  • Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer

    Nov 1, 2013, 00:00

  • Medication Errors-Incidence, Causes and Possible Prevention Strategies in Indian Health Care Setting

    Nov 1, 2013, 00:00

  • The Role of DSM in the EMA and FDA Authorization Process for Psychiatric Drugs

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Asenapine Versus Atypical Antipsychotics Used in Turkey in the Treatment of Bipolar I Disorder

    Nov 1, 2013, 00:00

  • Cross (-Walk) at Your Own Peril! Comparing and Contrasting Cea Results When Individual-Level Utilities Are Derived from External Mapping Algorithms Rather Than Actually Observed Responses

    Nov 1, 2013, 00:00

  • Assessing the Significance of HbA1c Durability in Cost Effectiveness Analysis of 2nd Line Oral Therapies in the Management of Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Evaluation of the Burden of Illness of Skin Cancer Among Veteran Patients United States

    Nov 1, 2013, 00:00

  • Pathological Gambling- A Growing Addiction

    Nov 1, 2013, 00:00

  • A Model to Evaluate the Immunogenicity Costs of Tumour Necrosis Factor-Alpha Inhibitors in Patients with Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Linezolid for the Treatment of Patients with Confirmed MRSA Nosocomial Pneumonia in Nanjing, China- A Cost Effective Alternative to Vancomycin

    Nov 1, 2013, 00:00

  • Study of Quality of Life and Costs for CML Patients in Bulgaria

    Nov 1, 2013, 00:00

  • Cost-Effectiveness and Cost-Utility Analysis of Mifamurtide Plus Combination Chemotherapy in Pediatric Patients with Osteosarcoma After Resection Surgery

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of 3 Candins and Fluconazole in the Treatment of Confirmed Invasive Candidiasis in Adult Non-Neutropaenic Patients in Spain

    Nov 1, 2013, 00:00
  • «
  • 111
  • 112
  • 113
  • 114
  • 115 (current)
  • 116
  • 117
  • 118
  • 119
  • 120
  • »